In vivo evaluation of leukocyte distribution by means of technetium 99m after intravenous administration of high doses of recombinant erythropoietin.
Bueml
M
M
Allegra
A
A
Baldari
S
S
Aloisi
C
C
Conte
C
C
Montalto
G
G
D000818:Animals; D002448:Cell Adhesion; D015815:Cell Adhesion Molecules / Q000097:blood; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D006801:Humans; D007958:Leukocyte Count / Q000379:methods*; D007962:Leukocytes / Q000502:physiology; D007970:Leukopenia / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology; D008833:Microcirculation; D015609:Organotechnetium Compounds; D010091:Oximes; D051381:Rats; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D019690:Technetium Tc 99m Exametazime
D015815:Cell Adhesion Molecules; D015609:Organotechnetium Compounds; D010091:Oximes; D011994:Recombinant Proteins; D004921:Erythropoietin; D019690:Technetium Tc 99m Exametazime